The company was established in Asia in China. The main department of described VC is located in the Beijing.
The current fund was established by Gavin Ni. The overall number of key employees were 1.
The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2017. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Zero2IPO Ventures works on 16 percentage points less the average amount of lead investments.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Zero2IPO Ventures, startups are often financed by IDG Capital, Sequoia Capital China, BlueRun Ventures. The meaningful sponsors for the fund in investment in the same round are IDG Capital, Matrix Partners China, Kleiner Perkins. In the next rounds fund is usually obtained by GGV Capital, Sequoia Capital China, Sequoia Capital.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Internet, Shopping. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Meilishuo, Bona Film Group, Yesmywine
Related Funds
Funds with similar focus
Fund Name | Location |
3K.com | - |
Atlanta Equity | Atlanta, Georgia, United States |
Bozhong.com | China, Guangdong, Guangzhou |
Business Solutions | Horsham, Pennsylvania, United States |
CATCHER TECHNOLO RG | Taipei, Taiwan |
Cattles Invoice Finance | Abingdon, Oxfordshire, United Kingdom |
CIH Investment Capital Limited | Central, Central Region, Singapore |
Connector Media | - |
Huijunfeng Zichan | China, Shanghai |
Newfire Global Partners | Cambridge, Massachusetts, United States |
RIC Capital Management | China, Shanghai |
Scientipole Ile-de-France Capital | France, Ile-de-France, Orsay |
Shanghai Lindian Wangluo Keji Youxian Gongsi | China, Shanghai |
Shenzhen Press Group | China, Guangdong, Shenzhen |
Telstra Ventures | California, San Francisco, United States |
Tuhua Fund | Auckland, Auckland, New Zealand |
UOB Investment | Beijing, China, Haidian |
Wind Capital | - |
Ying Feng Investment Create Value | China, Fujian, Xiamen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
HanchorBio | $20M | 25 Aug 2022 | Taipei, Taiwan | ||
AlpsenTek | $29M | 06 Jun 2022 | Zurich, Zurich, Switzerland | ||
Reistone Biopharma | $100M | 09 May 2022 | Pudong, Shandong, China | ||
Pleryon Therapeutics | $15M | 01 Apr 2022 | Shenzhen, Guangdong, China | ||
TsIntergy Technology | $15M | 04 Mar 2022 | Beijing, Beijing, China | ||
Scent Library | $10M | 16 Sep 2021 | Dongcheng, Shaanxi, China | ||
X-ABT | $7M | 24 Mar 2020 | Changping District, Beijing, China | ||
Happyeasygo Group | $45M | 12 Dec 2019 | Gurugram, Haryana, India | ||
$5M | 25 Oct 2019 | Guangxi |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
HanchorBio | $20M | 25 Aug 2022 | Taipei, Taiwan | ||
AlpsenTek | $29M | 06 Jun 2022 | Zurich, Zurich, Switzerland | ||
Reistone Biopharma | $100M | 09 May 2022 | Pudong, Shandong, China | ||
Pleryon Therapeutics | $15M | 01 Apr 2022 | Shenzhen, Guangdong, China | ||
TsIntergy Technology | $15M | 04 Mar 2022 | Beijing, Beijing, China | ||
Scent Library | $10M | 16 Sep 2021 | Dongcheng, Shaanxi, China | ||
X-ABT | $7M | 24 Mar 2020 | Changping District, Beijing, China | ||
Happyeasygo Group | $45M | 12 Dec 2019 | Gurugram, Haryana, India | ||
$5M | 25 Oct 2019 | Guangxi |